Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
detroit blog main
detroit top stories
2
×
healthcare
2
×
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
accelerator
adalimumab
administration
airbnb
albert bourla
amazon web services (aws)
artificial intelligence (a.i.)
astrazeneca
athelas
atomwise
benchling
biosimilar
biotech
biotechnology
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
What
admits
ago
away
big
biotechs
bringing
ceos
classes
combinator
companies
dc
drug
dug
executives
gathered
groups
hearing
held
incubator
life
lower
pharma
pharmaceutical
previously
prices
rebates
sciences
senate
seven
sizable
started
startup
tech
they’re
today
washington
welcome
years
Language
unset
Current search:
healthcare
×
" detroit top stories "
×
" new york blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
